Archive

According to the motto “We are creating a future with perspectives”, mid-sized companies were honored for their sustainable and successful management...

On the occasion of the visit of the German Chancellor Angela Merkel and the Minister of Economics Harry Glawe at CHEPLAPHARM in Greifswald, CEO...

The wholly owned subsidiary of Orexigen Therapeutics, Inc. (OREX), and CHEPLAPHARM Arzneimittel GmbH have executed a distributorship agreement...

The successful company from Greifswald, CHEPLAPHARM Arzneimittel GmbH, continues to grow: 50 new employees have been recruited in the past eight...

With an investment of approximately 340 million euros, CHEPLAPHARM Arzneimittel GmbH breaks all private sector records in Mecklenburg-Western...

Amount of investment in the mid, double-digit million euro range. CHEPLAPHARM creates eight new jobs with this acquisition.

CHEPLAPHARM acquired the product rights for the prescription medication ALDACTONE® in Italy on 09.11.2015, thus boosting its presence within this...

On December 1st CHEPLAPHARM Arzneimittel GmbH moved into a new prestigious office building at Ziegelhof Business Park in the outskirts of the...

The pharmaceutical firm CHEPLAPHARM Arzneimittel GmbH has embarked on the biggest ever investment program in the history of the company.

This...

Additionally, CHEPLAPHARM acquires Glenwood LLC based in New York, USA.

CHEPLAPHARM continues its rapid growth in 2013. The increase in sales...